Takahashi, T.; Terazono, H.; Suetsugu, T.; Sugawara, H.; Arima, J.; Nitta, M.; Tanabe, T.; Okutsu, K.; Ikeda, R.; Mizuno, K.;
et al. High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction. Cancers 2021, 13, 3425.
https://doi.org/10.3390/cancers13143425
AMA Style
Takahashi T, Terazono H, Suetsugu T, Sugawara H, Arima J, Nitta M, Tanabe T, Okutsu K, Ikeda R, Mizuno K,
et al. High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction. Cancers. 2021; 13(14):3425.
https://doi.org/10.3390/cancers13143425
Chicago/Turabian Style
Takahashi, Takayuki, Hideyuki Terazono, Takayuki Suetsugu, Hideki Sugawara, Junko Arima, Mina Nitta, Toru Tanabe, Kayu Okutsu, Ryuji Ikeda, Keiko Mizuno,
and et al. 2021. "High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction" Cancers 13, no. 14: 3425.
https://doi.org/10.3390/cancers13143425
APA Style
Takahashi, T., Terazono, H., Suetsugu, T., Sugawara, H., Arima, J., Nitta, M., Tanabe, T., Okutsu, K., Ikeda, R., Mizuno, K., Inoue, H., & Takeda, Y.
(2021). High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction. Cancers, 13(14), 3425.
https://doi.org/10.3390/cancers13143425
